ArticleBlood2010

Sequential treatment of CD34+ cells from patients with primary myelofibrosis with chromatin-modifying agents eliminate JAK2V617F-positive NOD/SCID marrow repopulating cells.

Xiaoli Wang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.